Euclidean Capital as of June 30, 2024
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf Tr Tr Unit (SPY) | 78.4 | $624M | 1.1M | 544.22 | |
Ishares Tr Msci India Etf (INDA) | 17.0 | $135M | 2.4M | 55.78 | |
Foghorn Therapeutics (FHTX) | 1.1 | $9.0M | 1.6M | 5.75 | |
Oric Pharmaceuticals (ORIC) | 0.9 | $7.0M | 989k | 7.07 | |
Alector (ALEC) | 0.7 | $5.9M | 1.3M | 4.54 | |
Pmv Pharmaceuticals (PMVP) | 0.5 | $4.3M | 2.6M | 1.62 | |
23andme Holding Class A Com (ME) | 0.5 | $4.0M | 10M | 0.39 | |
Tenaya Therapeutics (TNYA) | 0.4 | $3.1M | 1.0M | 3.10 | |
Rapt Therapeutics (RAPT) | 0.3 | $2.0M | 658k | 3.05 | |
Surrozen Com New (SRZN) | 0.1 | $960k | 88k | 10.95 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.8k | 171k | 0.02 |